Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Tumor Virus Infections D014412 8 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Pain D010146 64 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Wounds and Injuries D014947 20 associated lipids
Pleurisy D010998 20 associated lipids
Burns D002056 34 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Infertility, Male D007248 11 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Brain Injuries D001930 4 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Osteonecrosis D010020 5 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Gastritis D005756 27 associated lipids
Pulmonary Edema D011654 23 associated lipids
Coronary Disease D003327 70 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Pancreatitis D010195 10 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Rhinitis D012220 10 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Hynes AC et al. The phosphatidylinositol signalling system in elongating bovine blastocysts; formation of phosphoinositides, inositol phosphates and stimulation by growth factors. 2002 Reprod. Fertil. Dev. pmid:12617797
O'Neill C et al. Outcome of pregnancies resulting from a trial of supplementing human IVF culture media with platelet activating factor. 1992 Reprod. Fertil. Dev. pmid:1585005
Pike IL et al. Actions of platelet activating factor (PAF) on gametes and embryos: clinical aspects. 1992 Reprod. Fertil. Dev. pmid:1461991
O'Neill C Embryo-derived platelet activating factor. 1992 Reprod. Fertil. Dev. pmid:1438959
Dusting GJ and Stewart AG Overview of eicosanoid metabolism and relationship to platelet-activating factor. 1990 Reprod. Fertil. Dev. pmid:2075239
O'Neill C et al. Embryo-derived platelet activating factor: interactions with the arachidonic acid cascade and the establishment and maintenance of pregnancy. 1990 Reprod. Fertil. Dev. pmid:2075241
Bragado MJ et al. Platelet-activating factor in Iberian pig spermatozoa: receptor expression and role as enhancer of the calcium-induced acrosome reaction. 2011 Reprod. Domest. Anim. pmid:22023717
Schäfer-Somi S et al. Vascular endothelial (VEGF) and epithelial growth factor (EGF) as well as platelet-activating factor (PAF) and receptors are expressed in the early pregnant canine uterus. 2013 Reprod. Domest. Anim. pmid:22458960
Tiemann U The role of platelet-activating factor in the mammalian female reproductive tract. 2008 Reprod. Domest. Anim. pmid:18363604
Ali A et al. Essential role of platelet-activating factor in male reproduction: a review. 2007 Reprod. Biomed. Online pmid:17298732
Jin XL and O'Neill C Systematic analysis of the factors that adversely affect the rate of cell accumulation in mouse embryos during their culture in vitro. 2014 Reprod. Biol. Endocrinol. pmid:24885989
Seyffarth G et al. Lipopolysaccharide induces nitric oxide synthase expression and platelet-activating factor increases nitric oxide production in human fetal membranes in culture. 2004 Reprod. Biol. Endocrinol. pmid:15191613
Neerhof MG et al. The significance of endothelin in platelet-activating factor-induced fetal growth restriction. 2012 Reprod Sci pmid:22534337
Grinyó JM et al. The role of platelet-activating factor antagonists in the prophylaxis of posttransplant acute tubular necrosis. 1996 Ren Fail pmid:8827990
López-Novoa JM et al. The role of platelet-activating factor and the effect of PAF blocking receptors on the outcome of ARF. 1996 Ren Fail pmid:8827995
Pirotzky E et al. Platelet-activating factor antagonist, BN-52021 protects against cis-diamminedichloroplatinum nephrotoxicity in the rat. 1990 Ren Fail pmid:2287769
Tamaoki J et al. A human bronchial epithelial cell line releases arginine vasopressin: involvement of Ca2+ -activated K+ channels. 1998 Regul. Pept. pmid:9712168
Wallace JL et al. Protective effects of somatostatin against gastric damage induced by hemorrhagic shock, stress and PAF in the rat. 1993 Regul. Pept. pmid:7901873
Iwamoto I et al. Role of leukotriene B4 in substance P-induced granulocyte infiltration in mouse skin. 1993 Regul. Pept. pmid:7692497
Resetkova E et al. Effect of human thyroglobulin on the production of platelet activating factor from peripheral blood mononuclear cells from patients with autoimmune thyroid diseases. 1992 Jul-Aug Reg Immunol pmid:1476872
Ploppa A et al. Local anesthetic effects on human neutrophil priming and activation. 2010 Jan-Feb Reg Anesth Pain Med pmid:20048657
Carlson SA et al. Lack of constitutive activation or inactivation of the platelet-activating factor receptor by glutamate substitution of alanine 230. 1996 Recept Signal Transduct pmid:9015866
Kasperska-Zajac A et al. Platelet-activating factor (PAF): a review of its role in asthma and clinical efficacy of PAF antagonists in the disease therapy. 2008 Recent Pat Inflamm Allergy Drug Discov pmid:19075994
Incorvaia C et al. Anaphylaxis: an update on its understanding and management. 2010 Recent Pat Inflamm Allergy Drug Discov pmid:20100165
Weintraub ST et al. Electrospray ionization for analysis of platelet-activating factor. 1991 Rapid Commun. Mass Spectrom. pmid:1841648
Smith JC et al. Identification of lysophosphatidylcholine (LPC) and platelet activating factor (PAF) from PC12 cells and mouse cortex using liquid chromatography/multi-stage mass spectrometry (LC/MS3). 2008 Rapid Commun. Mass Spectrom. pmid:18937225
Barnes PJ The changing face of asthma. 1987 Q. J. Med. pmid:3310071
Templeton AG et al. Effects of S-salbutamol on human isolated bronchus. 1998 Pulm Pharmacol Ther pmid:9802957
Webber SE et al. PAF-induced secretory hyperresponsiveness in the ferret trachea to bradykinin and its pharmacological inhibition. 1997 Pulm Pharmacol Ther pmid:9514626
Manabe H et al. The inhaled administration of KF19514, a phosphodiesterase 4 and 1 inhibitor, prevents antigen-induced lung inflammation in guinea pigs. 2000 Pulm Pharmacol Ther pmid:10718985
Touvay C et al. Effect of long-term infusion of platelet-activating factor on pulmonary responsiveness and morphology in the guinea-pig. 1991 Pulm Pharmacol pmid:1804494
Salari H and Schellenberg RR Stimulation of human airway epithelial cells by platelet activating factor (PAF) and arachidonic acid produces 15-hydroxyeicosatetraenoic acid (15-HETE) capable of contracting bronchial smooth muscle. 1991 Pulm Pharmacol pmid:1804490
Macquin-Mavier I et al. Effects of platelet-activating factor on lung epithelial permeability in the guinea-pig. 1991 Pulm Pharmacol pmid:1806136
Underwood SL et al. RP 58802B, a long-acting beta 2-adrenoceptor agonist: assessment of antiasthma activity in the guinea-pig in vivo. 1992 Pulm Pharmacol pmid:1280178
Lai CK and Holgate ST Stimulation of human airway epithelial cells by platelet activating factor (PAF) and arachidonic acid produces 15-hydroxyeicosatetraenoic acid (15-HETE) capable of contracting bronchial smooth muscle. 1992 Pulm Pharmacol pmid:1591466
Spina D et al. The role of platelet activating factor in allergic inflammation. 1989 Pulm Pharmacol pmid:2520484
Björck T and Dahlén SE Leukotrienes and histamine mediate IgE-dependent contractions of human bronchi: pharmacological evidence obtained with tissues from asthmatic and non-asthmatic subjects. 1993 Pulm Pharmacol pmid:8477156
Teather LA et al. Platelet-activating factor antagonists decrease the inflammatory nociceptive response in rats. 2002 Psychopharmacology (Berl.) pmid:12373444
Chomyszyn-Gajewska M [Evaluation of chosen salivary periodontal disease markers]. 2010 Prz. Lek. pmid:20687387
Kuśnierz B and Naskalski JW [Mediators of the inflammatory response in the course of acute pancreatitis]. 1999 Prz. Lek. pmid:10575924
Myśliwiec M and Myśliwiec B [Blood platelets, prostaglandin and complement interactions in inflammation]. 1982 Prz. Lek. pmid:6753039
Gui C et al. Understanding the regulation mechanisms of PAF receptor by agonists and antagonists: molecular modeling and molecular dynamics simulation studies. 2007 Proteins pmid:17243151
Aquino EN et al. Proteomic Analysis of Neutrophil Priming by PAF. 2016 Protein Pept. Lett. pmid:26631175
Chérifi F et al. Isolation, functional characterization and proteomic identification of CC2-PLA₂ from Cerastes cerastes venom: a basic platelet-aggregation-inhibiting factor. 2014 Protein J. pmid:24384926
Fonseca FV et al. Characterization of a new platelet aggregating factor from crotoxin Crotalus durissus cascavella venom. 2006 Protein J. pmid:16729248
Ho YS et al. Probing the substrate specificity of the intracellular brain platelet-activating factor acetylhydrolase. 1999 Protein Eng. pmid:10469831
Miguel BG et al. Increase of phosphoinositide hydrolysis and diacylglycerol production by PAF in isolated rat liver nuclei. 2001 Prostaglandins Other Lipid Mediat. pmid:11444588
Benito E and Bosch MA Role of platelet-activating factor in phosphatidylcholine secretion in primary cultures of rat type II pneumocytes. 2002 Prostaglandins Other Lipid Mediat. pmid:12013527
Ishii S et al. Platelet-activating factor receptor. 2002 Prostaglandins Other Lipid Mediat. pmid:12432946
Vlachogianni IC et al. Platelet Activating Factor (PAF) biosynthesis is inhibited by phenolic compounds in U-937 cells under inflammatory conditions. 2015 Prostaglandins Other Lipid Mediat. pmid:26358846